Kantara, C., Moya, S.M., Houchen, C.W., Umar, S., Ullrich, R.L., Singh, P. and Carney, D.H. (2015) Novel regenerative peptide TP508 mitigates radiation-induced gastrointestinal damage by activating stem cells and preserving crypt integrity. Lab Invest. Aug 17.
Chrysalis BioTherapeutics, Inc. is committed to helping improve people’s lives through innovation.
GALVESTON, Texas–(BUSINESS WIRE)–Chrysalis BioTherapeutics, Inc. announced today that the US Food and Drug
GALVESTON An island biopharmaceutical company has received U.S. Food and Drug Administration clearance
a. Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled
We answer all email and requests as they come in. If you have an urgent matter or would like to place an order please click the link below to give us a call.
Chrysalis BioTherapeutics, Inc. is committed to helping improve people’s lives through innovation.